Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review (original) (raw)
References
Hildebrand J: Radiotherapy and chemotherapy of malignant brain gliomas. Drugs Exptl Clin Res 12: 167–175, 1986 Google Scholar
Levin VA, Wara WM, Davis RL, Silver R, Resser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB: Northern California oncology group protocol 6G91: Response to treatment with radiation therapy and seven-drug chemotherapy in patients with glioblastoma multiforme. Cancer Treatment Reports 70: 739–743, 1986 Google Scholar
Johnson DW, Parkinson D, Wolpert SM, Kasdon D, Kwan ES, Laucella M, Anderson ML: Intracarotid chemotherapy with 1,3-Bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma. Neurosurgery 20: 577–583, 1987 Google Scholar
Gumerlock MK, Neuwelt EA: Principles of chemotherapy in brain neoplasia. In: Jellinger K (ed) Therapy of Malignant Brain Tumors. Springer-Verlag, Vienna 277–348, 1987 Google Scholar
Groothuis DR, Molnar P, Blasberg RG: Regional blood flow and blood-to-tissue transport in five brain tumor models. Prog Exp Tumor Res 27: 132–153, 1984 Google Scholar
Poplack DG, Bleyer WA, Horowitz ME: Pharmacology of antineoplastic agents in cerebrospinal fluid. In: Wood JH (ed) Neurobiology of Cerebrospinal fluid 1. Plenum Press, New York 561–578, 1980 Google Scholar
Neuwelt EA, Howieson J, Frenkel EP, Specht HD, Weigel R, Buchan CG, Hill SA: Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain bririer modification in glioblastoma. Neurosurgery 19: 573–582, 1986 Google Scholar
Bonstelle CT, Kori SH, Rekate H: Intracarotid chemotherapy of glioblastoma after induced blood-brain barrier disruption. Am J Neurorad 4: 810–812, 1983 Google Scholar
Fauchon F, Chiras J, Poisson M, Rose M, Terrier L, Bories J, Guerin RA: Intra-arterial chemotherapy by cisplatin and cytarabine after temporary disruption of the blood-brain barrier for the treatment of malignant gliomas in adults. J Neuroradiol 13: 151–162, 1986 Google Scholar
Heimberger K, Samec P, Podreka I, Binder H, Suess E, Reisner T, Deecke L, Steger G, Hiesmayr M, Dittrich C, Horaczek A, Zimpfer M: [Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas]. Wien Klin Wochenschr 99: 385–388, 1987 Google Scholar
Hiesmayr M, Dirnberger H, Aloy A, Heimberger K, Horaczek A, Brandstatter B, Zimpfer M: [Hemodynamic effects of an osmotic bolus for the reversible opening of the blood-brain barrier]. Schweiz Med Wochenschr 117: 450–454, 1987 Google Scholar
Li V, Levin AB, Turski P: Intra-arterial chemotherapy following blood-brain barrier disruption in patients with recurrent high grade astrocytomas. Abstract, Proc Am Ass Neurol Surg p404, 274, Toronto, Canada, April 1988
Miyagami M, Kagawa Y, Tusbokawa T: [ACNU delivery to malignant glioma tissue by osmotic blood brain barrier modification with intracarotid infusion of hyperosmolar mannitol]. No Shinkei Geka 13: 955–963, 1985 Google Scholar
Sato S, Toya S, Otani M: [Barrier opening microcirculation in human brain tumor]. Brain and Nerve (Japan) 37: 109–113, 1985 Google Scholar
Sato S, Yoshinori A, Kodama R, Fujioka M, Otani M, Inoue H, Toya S: ]Blood-brain barrier opening CT]. Progress in Computerized Tomography (Japan) 7: 43–48, 1985 Google Scholar
Suda K, Nakasu S, Saito A: Ocular complication of combined intracarotid chemotherapy and osmotic blood-brain barrier disruption. Arch Jpn Chir 54: 359–363, 1985 Google Scholar
Williams WT, Lowry RL, Eggers GWN: Anesthetic management during therapeutic disruption of the blood-brain barrier. Anesth Analg 65: 188–190, 1986 Google Scholar
Neuwelt EA, Frenkel EP, Gumerlock MK, Braziel R, Dana B, Hill SA: Developments in the diagnosis and treatment of primary CNS lymphoma: A prospective series. Cancer 58: 1609–1620, 1986 Google Scholar
Schag CC, Heinrich RL, Ganz PA: Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 2: 187–193, 1984 Google Scholar
Neuwelt EA, Dahlborg SA: Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases. J Neuro-Oncol 4: 195–207, 1987 Google Scholar
Neuwelt EA, Barnett PA, Frenkel EP: Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: Observations on problems of drug delivery. Neurosurgery 14: 154–159, 1984 Google Scholar
Neuwelt EA, Glasberg M, Diehl J, Frenkel EP, Barnett P: Osmotic blood-brain barrier disruption in the posterior fossa of the dog. J Neurosurg 55: 742–748, 1981 Google Scholar
Millay RH, Klein ML, Shults WT, Dahlborg SA, Neuwelt EA: Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am J Ophth 102: 626–632, 1986 Google Scholar
Miller DF, Bay JW, Lederman RJ, Purvis JD, Rogers LR, Tomsak RL: Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas. Ophthalmology 92: 402–406, 1985 Google Scholar